The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concern...

Providing details of the efficacy rate of Covaxin and Covishield vaccines against each of the mutations, he said there was no significant d...

In lab experiments, the shot demonstrated “roughly equivalent” levels of neutralising activity against the Brazil and UK strains compared w...

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...

Health Minister Zweli Mkhize said the government had placed "huge orders on J&J and Pfizer which will be finalised in the next few days and...

A phase I/II trial conducted by University of Witwatersrand and Oxford University on 2,000 volunteers with a median age of 31 years found t...

Authorities in South Africa have recorded almost half of the COVID-19 deaths in all of Africa and over a third of confirmed infections on t...

Researchers began this work months ago when the variants were first detected, said Mene Pangalos, head of biopharmaceuticals research for A...

J&J vaccines will be used to launch the first phase of South Africa's vaccination drive in which the country's 1.25 million health care wor...

"I think the jury is out on that at the moment, but all developers are preparing new vaccines so if we do need them, we'll have them availa...

In a nationwide broadcast on Sunday evening, Health Minister Mkhize said that the roll-out will be put on hold until a committee of scienti...

Developers of the Oxford-AstraZeneca vaccine expect to have a modified jab to cope with the South Africa coronavirus variant by autumn, the...

SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make u...

The price is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the same vaccines under an...

The vaccine, developed with the University of Oxford, is made from a virus which is a weakened version of a common cold virus (adenovirus),...

Regulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...

Serum said it has enrolled 1,600 participants in India for late-stage trials of AstraZeneca's candidate, and also plans to seek regulatory ...